云南高校图书馆联盟文献共享服务平台- Infectious Diseases & Immunity

《Infectious Diseases & Immunity》: 作品数：141被引量：50H指数：3; 导出分析报告; 主办单位：中华医学会; 最新期次：2024年4期更多>>; 发文主题：SARS-COVPATIENTSINFECTIONVACCINEHIV更多>>; 发文领域：医药卫生文化科学自动化与计算机技术更多>>; 发文基金：国家自然科学基金北京市自然科学基金国家重点基础研究发展计划更多>>

Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome Prevention and Control in China:Statistics,Challenges,and the Road Ahead: 《Infectious Diseases & Immunity》2024年第4期149-151,共3页Sitong Luo Ning Wang; supported by the Capital’s Funds for Health Improvement and Research(CFH:2024-2G-4402).; 1.Background,Forty years have passed since the initial discovery and isolation of the human immunodeficiency virus(HIV)in 1984.[1,2]At the end of 2022,approximately 85.6 million people had been infected with the virus...; 关键词：IMMUNODEFICIENCY IMMUNODEFICIENCY globally

The New Era for Respiratory Syncytial Virus Prevention for Infants in China:A Pediatricians’Perspective: 《Infectious Diseases & Immunity》2024年第4期152-155,共4页Lisu Huang Zhimin Chen Mei Zeng; supported by the Shanghai municipal three-year action plan for strengthening the construction of the public health system(2023-2025)GWVI-2.1.2.; This year marks a new era for respiratory syncytial virus(RSV)prevention for infants in China,as it is the first time since the detection of RSV that we have an option,namely,the long-acting monoclonal antibody nirsev...; 关键词：PREVENTION RESPIRATORY MONOCLONAL

Manipulating the 4-1BB Pathway to Cure HBV: 《Infectious Diseases & Immunity》2024年第4期156-157,共2页Zhang Chao Wang Fu-Sheng; supported by the National Key Research and Development Program of China(2022YFA1303600 and 2023YFC2308100);the National Natural Science Foundation of China(82130019).; Chronic Hepatitis B Virus(HBV)infection is a major global health issue leading to liver cirrhosis and hepatocellular carcinoma.Currently available treatments have limited efficacy in completely eradicating the virus.; 关键词：CIRRHOSIS INFECTION HEPATOCELLULAR

Expert Consensus on the Clinical Application of Oral Small-molecule Antiviral Drugs Against COVID-19: 《Infectious Diseases & Immunity》2024年第4期158-169,共12页无 Nanshan Zhong Guiqiang Wang; Emergency Key Program of Guangzhou Laboratory(EKPG21-06);the Macao Science and Technology Development Fund(0022/2021/A1);the Young Top Talent of Science and Technology Innovation Department of Guangdong Province(2021TQ060189);National Administration of Traditional Chinese Medicine’s Interdisciplinary Innovation Team Project(ZYYCXTU-D-202201).; Although COVID‑19 no longer constitutes a“public health emergency of international concern”,which still has being spreading around the world at a low level.Small molecule drugs are the main antiviral treatment for n...; 关键词：Coronavirus infections Antiviral therapy Small molecule drugs Early stage Expert consensus

Characteristics and Risk Factors of Infections among Patients with Autoimmune Bullous Diseases: A Retrospective Single-Center Study in China: 《Infectious Diseases & Immunity》2024年第4期170-177,共8页Feiran Zhou Xiaoping Zheng Yixuan Yang Qingluan Yang Jingyu Zhou Haoxin Xu Xiaoqun Luo Lingyun Shao Wenhong Zhang Zhonghua Li Qiaoling Ruan; supported by National Natural Science Foundation of China(82271794 and 82302533);Shanghai Science and Technology Commission sailing project(22YF1404900).; Background: Since infections can lead to adverse outcomes in autoimmune bullous diseases (AIBD), this study aimed to analyze infection characteristics in AIBD, predict infection risk factors and provide probable sugge...; 关键词：PEMPHIGUS Bullous pemphigoid GLUCOCORTICOIDS INFECTIONS Retrospective studies

Safety Profile of COVID-19 Vaccines in HIV Patients Undergoing ART and Their Impact on Immune Recovery and HIV Reservoirs: 《Infectious Diseases & Immunity》2024年第4期178-186,共9页Bing Song Xinhua Wang Lin Shen Juan Cheng Jing Tian Chunjie Zhang Zhuanghong Zhao Yuting Zhou Rong Liang Zihan Zhou Xinyi Yang Xuhai Suo Tianjun Jiang Huihuang Huang Qun Guan Ying Yang Bingke Bai; supported by the National Natural Science Foundation of China(8227060482).; Background:While some studies have reported the impact of COVID-19 vaccines on immune recovery and human immunodeficiency virus(HIV)reservoirs in persons living with HIV(PLWH),their findings remain inconsistent.Furthe...; 关键词：HIV patients COVID-19 vaccine CA HIV DNA CA HIV RNA

The Interplay Between Schistosomiasis and Hepatitis C Virus:Battling on Two Fronts: 《Infectious Diseases & Immunity》2024年第4期187-193,共7页Nahed A Makhlouf Ahmed Abu-Elfatth Tasneem Khaled Mohamed El-Kassas; Schistosomiasis is a prevalent health issue in numerous countries in Africa,Asia,and South America.Data regarding the coinfection of schistosomiasis with hepatitis C virus(HCV)is limited,yet this coinfection is preval...; 关键词：Hepatitis C virus SCHISTOSOMIASIS Portal fibrosis Liver cirrhosis Hepatocellular carcinoma

CAR-T Therapy in HIV:Pioneering Advances and Navigating Challenges: 《Infectious Diseases & Immunity》2024年第4期194-205,共12页Xiao Wang Jianyang Liu Feike Hao Tatchapon Ajavavarakula Xuanling Shi; supported by the National Key Research and Development Program of China(2022YFC2604100);the National Science and Technology Major Project(2018ZX10302104-003).; Chimeric antigen receptor T(CAR-T)cell therapy,renowned for its successes in cancer treatment,is now entering the field of human immunodeficiency virus(HIV)therapy,presenting both opportunities and challenges.With the...; 关键词：HIV AIDS CAR-T cell therapy functional cure immune cells

Serological Detection of West Nile Virus in Single-Humped Camels in Northern Nigeria: 《Infectious Diseases & Immunity》2024年第4期206-208,共3页Anyebe B.Onoja Meschach M.Maina Arhyel Malgwi Bukang Ali Emmanuel David Shedrach B.Pewan Reuben S.Bala Abdulrahman M.Adeiza Andrew M.Adamu Oyelola A.Adegboye; 1.Introduction,West Nile virus(WNV)is an important arbovirus that affects both animals and humans.It is a flavivirus member of the Flaviviridae family and is primarily spread by Culex mosquitoes.The main enzootic cycl...; 关键词：APPARENT primarily WEST

Clinical Trials of Respiratory Virus Infections: How to Address Challenges and Prepare for the Future: 《Infectious Diseases & Immunity》2024年第3期101-102,共2页Jingwen Ai Wenhong Zhang; supported by National Natural Science Foundation of China(82341033,82161138018);National Key Research and Development Program(2023YFC3043507).; 1.Backgrounds Prior to the coronavirus disease 2019(COVID-19)outbreak,the only antiviral treatment widely used in clinical settings was for influenza.However,following the global pandemic,there has been renewed resear...; 关键词：CLINICAL RESPIRATORY CLINICAL

《Infectious Diseases & Immunity》